Your browser doesn't support javascript.
An antiviral trap made of protein nanofibrils and iron oxyhydroxide nanoparticles.
Palika, Archana; Armanious, Antonius; Rahimi, Akram; Medaglia, Chiara; Gasbarri, Matteo; Handschin, Stephan; Rossi, Antonella; Pohl, Marie O; Busnadiego, Idoia; Gübeli, Christian; Anjanappa, Ravi B; Bolisetty, Sreenath; Peydayesh, Mohammad; Stertz, Silke; Hale, Benjamin G; Tapparel, Caroline; Stellacci, Francesco; Mezzenga, Raffaele.
  • Palika A; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.
  • Armanious A; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.
  • Rahimi A; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.
  • Medaglia C; BluAct Technologies GmbH, Zurich, Switzerland.
  • Gasbarri M; Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland.
  • Handschin S; Institute of Materials, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
  • Rossi A; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.
  • Pohl MO; Department of Chemical and Geological Science, University of Cagliari, Cagliari, Italy.
  • Busnadiego I; Department of Materials, ETH Zurich, Zurich, Switzerland.
  • Gübeli C; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Anjanappa RB; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Bolisetty S; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.
  • Peydayesh M; Department of Biology, ETH Zurich, Zurich, Switzerland.
  • Stertz S; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.
  • Hale BG; BluAct Technologies GmbH, Zurich, Switzerland.
  • Tapparel C; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.
  • Stellacci F; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Mezzenga R; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Nat Nanotechnol ; 16(8): 918-925, 2021 08.
Article in English | MEDLINE | ID: covidwho-1260944
ABSTRACT
Minimizing the spread of viruses in the environment is the first defence line when fighting outbreaks and pandemics, but the current COVID-19 pandemic demonstrates how difficult this is on a global scale, particularly in a sustainable and environmentally friendly way. Here we introduce and develop a sustainable and biodegradable antiviral filtration membrane composed of amyloid nanofibrils made from food-grade milk proteins and iron oxyhydroxide nanoparticles synthesized in situ from iron salts by simple pH tuning. Thus, all the membrane components are made of environmentally friendly, non-toxic and widely available materials. The membrane has outstanding efficacy against a broad range of viruses, which include enveloped, non-enveloped, airborne and waterborne viruses, such as SARS-CoV-2, H1N1 (the influenza A virus strain responsible for the swine flu pandemic in 2009) and enterovirus 71 (a non-enveloped virus resistant to harsh conditions, such as highly acidic pH), which highlights a possible role in fighting the current and future viral outbreaks and pandemics.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Ferric Compounds / Nanoparticles / Amyloid / Micropore Filters Limits: Humans Language: English Journal: Nat Nanotechnol Year: 2021 Document Type: Article Affiliation country: S41565-021-00920-5

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Ferric Compounds / Nanoparticles / Amyloid / Micropore Filters Limits: Humans Language: English Journal: Nat Nanotechnol Year: 2021 Document Type: Article Affiliation country: S41565-021-00920-5